Log in to your Inderes Free account to see all free content on this page.
Create account

Peptonic Medical

0.00 SEK

0.00 %

Less than 1K followers

PMED

Spotlight Stock Market

Biotechnology & Pharmaceuticals

Health Care

0.00 %
0.00 %
-37.50 %
-44.44 %
-38.27 %
-72.22 %
-98.20 %
-99.81 %
-99.94 %

Peptonic Medical is a biomedical company that conducts research and development of pharmaceuticals and medical devices in the field of women's health. The company's vision is to offer treatments for women-specific diseases and medical conditions. For example, hormone-free products are being developed for the treatment of vaginal atrophy and vaginal dryness. Peptonic Medical has its headquarters in Bromma.

Read more
Market cap
20.72M SEK
Turnover
2.15K SEK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
27.5.
2026

Interim report Q1'26

10.6.
2026

General meeting '26

19.8.
2026

Interim report Q2'26

ShowingAll content types

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio
Create account
Forum discussions
Annual report released: FULL YEAR 2022 (Jan-Dec) Net sales of products 43,634 (31,643) tkr Gross profit 23,394 (19,070) tkr, 54% (60%) Operating loss -33,606 (-73,718) tkr Loss per share -0.15 (-0.38) kr The good thing is that sales have continued to grow. They also boasted about...
3/20/2023, 12:12 PM
by Old_man
8
I quickly found out that a new rights issue is on the way. For every current share, you would receive 4 new shares. And the price, if you then buy/exercise them, would be 0.01 SEK/share.
4/17/2024, 8:11 AM
by artuzo
3
Peptonic Medical (PMED:SS) today announced that it has signed a non-exclusive agreement with the medical technology company Siemens Healthineers for the distribution of Peptonic’s portfolio of diagnostic products for vaginal health. The agreement with Siemens Healthineers is global...
4/20/2023, 2:07 PM
by Old_man
3
STOCKHOLM (Nyhetsbyrån Direkt) Medtech company Peptonic Medical has decided to file an application for corporate restructuring. “The decision is an extraordinary measure due to a long-term strained liquidity situation and aims to create conditions for a stable and profitable business...
3/13/2025, 10:55 AM
by Old_man
2
Peptonic Medical AB (publ) (“Peptonic”) announced today that the company has agreed with the world’s largest retail chain Walmart to begin selling Peptonic’s self-test for bacterial vaginosis. The US is an important market. It is very gratifying that Walmart has decided to sell our...
10/11/2023, 8:04 AM
by Old_man
2
2023-06-15 13:00:00 - Cision International PEPTONIC Medical AB : Peptonic and Pharmiva sign letter of intent to merge and create a leading intimate women’s health company The FemTech companies PEPTONIC medical AB (“Peptonic”), listed on Spotlight Stock Market, and Pharmiva AB (publ...
6/15/2023, 12:42 PM
by Old_man
2
Peptonic Medical AB (publ) today announced that an arbitration court in China has ruled in favor of Peptonic in a dispute with Yuanjia Biotechnology Co., Ltd. In November 2020 and February 2021, Peptonic Medical shipped goods to Yuanjia Bio in China for a total value of 406,000 EUR...
6/9/2023, 7:30 AM
by Old_man
2
Read more on our forum
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.